BioVaxys Expands Vaccine Development with Secured GMP-Grade Lipid Supply#Canada#Vancouver#BioVaxys#DPX_Technology#GMP-grade_Lipid
BioVaxys Expands Vaccine Development with Secured GMP-Grade Lipid Supply
BioVaxys Technology Corp. has secured a significant supply of GMP-grade lipids to advance its DPX-based vaccine development, aiming for clinical trials.
third-news.com
December 17, 2024 at 12:21 PM
BioVaxys Expands Vaccine Development with Secured GMP-Grade Lipid Supply#Canada#Vancouver#BioVaxys#DPX_Technology#GMP-grade_Lipid